Director Shareholding

RNS Number : 5710F
Accrol Group Holdings PLC
16 July 2021
 

16 July 2021

 

Accrol Group Holdings plc

 

(the "Company")

 

Director Shareholding

 

Accrol (AIM: ACRL), the UK's leading independent tissue convertor, announces that Gareth Jenkins, Chief Executive Officer, has advised the Company that he has transferred 3,741,346 shares in the Company ("Shares") in which he was the direct beneficial owner to his wife, Susan Jenkins.

 

The total number of Shares owned and deemed to be under the control of Gareth Jenkins remains unchanged at 4,265,632.

 

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018, provides further detail.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

(i) G areth Jenkins

(ii) Susan Jenkins

2

Reason for the notification

a)

Position/status

(i) Chief Executive Officer

(ii) PCA of Chief Executive Officer

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Accrol Group Holdings plc

b)

LEI

213800MC56M5G69RJ226

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of £0.001

 

ISIN: GB00BZ6VT592

b)

Nature of the transaction

Transfer of shares

c)

Price(s) and volume(s)

  Price(s)

Volume(s)

(i) Nil

(ii) Nil

(i) 3,741,346

(ii) 3,741,346

d)

Aggregated information

- Aggregated volume

- Price


N/A - single transaction

e)

Date of the transaction

16 July 2021

f)

Place of the transaction

Off market transaction

 

 

 

For further information, please contact:




Accrol Group Holdings plc

Via Belvedere Communications

Dan Wright, Executive Chairman


Gareth Jenkins, Chief Executive Officer


Richard Newman, Chief Financial Officer




Zeus Capital Limited (Nominated Adviser & Broker) 


Dan Bate / Jordan Warburton

 +44 (0) 161 831 1512

Dominic King / John Goold

 

 

+44 (0) 203 829 5000

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

 


Belvedere Communications Limited


Cat Valentine

+44 (0) 7715 769 078

Keeley Clarke

+44 (0) 7967 816 525

Llew Angus

+44 (0) 7407 023 147


accrolpr@belvederepr.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASXKFDSFEFA
UK 100

Latest directors dealings